[Control of leukaemic and normal myeloid haemopoietic cells (author's transl)]

The proliferation of myeloid haemopoietic stem cells is absolutely dependent on the presence of a heterogeneous group of proteins with colony stimulating activity (CSA). CSA is generated by monocytes and lymphocytes. The estimation of the molecular weight of colony stimulating factors from both cell lines demonstrates a non-identity. All monocyte derived molecular weight fractions induce differentiation of myeloid stem cells into granulocytes and macrophages. Lymphocyte derived factors have identical biologic activity, with the exeption of one factor which promotes differentiation into eosinophilic granulocytes. Granulocytes release factors which inhibit the growth of myeloid stem cells. Blasts from patients with acute leukaemia do not generate significant amounts of colony stimulating activity, however, in four of nine cases investigated the production of inhibitors for normal stem cell growth is found. Blasts from patients with chronic myeloid leukaemia in blast crisis may be capable of producing colony stimulating activity. Granulocytes from patients with chronic myeloid leukaemia in the chronic phase exhibit no measurable release of inhibitors of myeloid stem cells. In myeloid leukaemias the normal leukocyte population is entirely or partially replaced by leukaemic leukocytes; thus, the proliferation of leukaemic and normal haemopoietic cells is likely to occur under abnormal control.

Related Concept Videos

Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
Disorders of Leukocytes01:27

Disorders of Leukocytes

Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...